Sign in
CompletedNo phase

Dynamic FDG PET/CT Imaging in Hepatocellular Carcinoma

Key facts

Who runs it
First Affiliated Hospital of Chongqing Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
24 people enrolled
Started
1 Dec 2025
Ended
11 Aug 2026
Type of study
Interventional
Treatments tested
  • Dynamic and static FDG PET/CT
Record updated
18 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Clinically suspected hepatocellular carcinoma
  • Ability to undergo the study PET/CT acquisition and provide written informed consent
  • A target liver lesion at least 1.5 cm in diameter, as specified in the current manuscript
  • Histopathological assessment and follow-up information available as required by the protocol

Who cannot take part

  • Another concurrent malignancy
  • Recent transarterial chemoembolisation, radiotherapy or systemic therapy
  • Active gastrointestinal bleeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Static fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) may be negative in hepatocellular carcinoma even when a tumour is present. Dynamic PET/CT records how the tracer enters, accumulates in and leaves tissues over time. This study evaluates whether kinetic parameter maps provide additional information at the sites of liver tumours that are negative on static FDG PET/CT. Imaging measurements are compared between static FDG-positive and FDG-negative lesions and related to histopathology. Associations with tissue expression of glucose-6-phosphatase, glucose transporter 1, glypican-3 and hexokinase II are also explored.

The group in the trial

  • Dynamic and static PET imagingOther group

    Treatment: Dynamic and static FDG PET/CT

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Diagnostic Value of [18F]FDG Total-Body Dynamic Imaging in Patients With Hepatocellular Carcinoma
Record updated
18 November 2026